Genetic homogeneity of the Camurati-Engelmann disease [2]

Clinical Genetics

Volumn 58, Issue 2, 2000, Pages 150-152

  Xavier, A B C F ^a   Saraiva, J M ^a   Le Merrer, M ^a   Dagoneau, N ^a   Huber, C ^a   Penet, C ^a   Munnich, A ^a   Cormier Daire, V ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; MICROSATELLITE DNA; NEUROTRANSMITTER; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1;

AUTOSOMAL DOMINANT DISORDER; CAMURATI ENGELMANN SYNDROME; CHROMOSOME 19; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAPHYSIS DYSPLASIA; EXON; FAMILY; GAIT DISORDER; GENE AMPLIFICATION; GENE ASSIGNMENT; GENE LOCUS; GENE MAPPING; GENE SEQUENCE; HAPLOTYPE; HUMAN; LETTER; LONG BONE; MUSCLE WEAKNESS; ONCOGENE C FOS; OSSIFICATION; OSTEOSCLEROSIS; PORTUGAL; PRIORITY JOURNAL; SKULL BASE;

EID: 0033848443     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2000.580211.x     Document Type: Letter

References (9)

1. Genetic mapping of the Camurati-Engelmann disease locus to 19q13.1-q13.3
2. Progressive Diaphyseal Dysplasia: A three-generation family with markedly variable expressivity
3. Fosl1 is a transcription target of c-fos during osteoblast differentiation
4. Selective expression of fos- and jun-related genes during proliferation and differentiation
5. Deregulated c-fos expression interferes with normal bone development in transgenic mice
6. Bone and haematopoietic defects in mice lacking c-fos
7. Pleiotropic effects of a null mutation in the c-fos proto-oncogene
8. C-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling
9. Automated DNA sequencing and analysis of 106 kilobases from human chromosome 19q13.3